| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |